Protalix BioTherapeutics Reports Second Quarter 2021 Financial Results and Financial and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. SPY
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Protalix BioTherapeutics Reports Second Quarter 2021 Financial Results and Financial and Business Update

Protalix BioTherapeutics (PLX) Misses Q2 EPS by 17c

August 16, 2021 6:55 AM EDT

Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.25), $0.17 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $6.43 million versus the consensus estimate of $8.3 million.

For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.

... More